PT1019426E - Agonistas e antagonistas do receptor de adenosina a1 - Google Patents

Agonistas e antagonistas do receptor de adenosina a1

Info

Publication number
PT1019426E
PT1019426E PT96945316T PT96945316T PT1019426E PT 1019426 E PT1019426 E PT 1019426E PT 96945316 T PT96945316 T PT 96945316T PT 96945316 T PT96945316 T PT 96945316T PT 1019426 E PT1019426 E PT 1019426E
Authority
PT
Portugal
Prior art keywords
antagonists
agents
adenosin
receptor
compositions
Prior art date
Application number
PT96945316T
Other languages
English (en)
Inventor
Luiz Belardinelli
Ray Olsson
Peter J Scammells
Peter Gerard Milder
Jurg R Pfister
Stephen Baker
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of PT1019426E publication Critical patent/PT1019426E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PT96945316T 1995-12-29 1996-12-26 Agonistas e antagonistas do receptor de adenosina a1 PT1019426E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/581,655 US5736528A (en) 1993-10-28 1995-12-29 N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists

Publications (1)

Publication Number Publication Date
PT1019426E true PT1019426E (pt) 2003-07-31

Family

ID=24326044

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96945316T PT1019426E (pt) 1995-12-29 1996-12-26 Agonistas e antagonistas do receptor de adenosina a1

Country Status (15)

Country Link
US (2) US5736528A (pt)
EP (1) EP1019426B1 (pt)
JP (1) JP2000502712A (pt)
KR (1) KR19990076916A (pt)
CN (1) CN1163502C (pt)
AT (1) ATE234322T1 (pt)
AU (1) AU728439B2 (pt)
BR (1) BR9612324A (pt)
CA (1) CA2238736C (pt)
DE (1) DE69626705T2 (pt)
DK (1) DK1019426T3 (pt)
ES (1) ES2190487T3 (pt)
NZ (1) NZ326608A (pt)
PT (1) PT1019426E (pt)
WO (1) WO1997024363A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
US6790839B2 (en) 1999-01-07 2004-09-14 Can-Fite Biopharma Ltd. Pharmaceutical administration of adenosine agonists
IL127947A0 (en) 1999-01-07 1999-11-30 Can Fite Technologies Ltd Pharmaceutical use of adenosine agonists
US6576620B2 (en) * 1999-12-03 2003-06-10 Cv Therapeutics, Inc. Method of identifying partial adenosine A1 receptor agonists
US20030008841A1 (en) * 2000-08-30 2003-01-09 Rene Devos Anti-HCV nucleoside derivatives
HUP0302685A3 (en) 2000-09-08 2005-02-28 Cv Therapeutics Inc Palo Alto Purine ribosides as antiarrhythmics
CA2347879A1 (en) 2001-05-11 2002-11-11 Vanderbilt University Substituted dicinnamoylquinides and their use in augmentation of adenosine function
EP1494685B1 (en) * 2002-04-18 2008-12-31 Cv Therapeutics, Inc. Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker
US20040121406A1 (en) * 2002-05-23 2004-06-24 Wilson Constance Neely Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
EP1513848A4 (en) * 2002-06-12 2005-11-09 Biogen Idec Inc METHOD FOR TREATING ISCHEMIA REPERFUSION INJURIES WITH ADENOSINE RECEPTOR ANTAGONISTS
US20040229901A1 (en) * 2003-02-24 2004-11-18 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist
US20060293312A1 (en) * 2003-04-25 2006-12-28 Howard Dittrich Method of improved diuresis in individuals with impaired renal function
EP1932529A1 (en) 2003-04-25 2008-06-18 Novacardia, Inc. Method of improved diuresis in individuals with impaired renal function
NZ543109A (en) * 2003-04-25 2008-06-30 Novacardia Inc Method of improved diuresis in individuals with impaired renal function
US20050239759A1 (en) * 2004-04-16 2005-10-27 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist and an aldosterone inhibitor
US7781402B2 (en) * 2004-10-12 2010-08-24 Closed Loop Therapies Ltd. Methods and implantable devices for treating supraventricular arrhythmias
ES2273599B1 (es) * 2005-10-14 2008-06-01 Universidad De Barcelona Compuestos para el tratamiento de la fibrilacion auricular.
CN101466383A (zh) * 2006-06-16 2009-06-24 美国诺华卡迪亚公司 包含低频率投与aa1ra的肾功能延长改善
US20090197900A1 (en) * 2007-03-29 2009-08-06 Howard Dittrich Methods of treating heart failure and renal dysfunction in individuals with an adenosine a1 receptor antagonist
US20080242684A1 (en) * 2007-03-29 2008-10-02 Howard Dittrich Methods of administration of adenosine a1 receptor antagonists
DE102011005232A1 (de) 2011-03-08 2012-09-13 AristoCon GmbH & Co. KG Adenosin und seine Derivate zur Verwendung in der Schmerztherapie
TWI653227B (zh) * 2014-07-11 2019-03-11 美商陶氏農業科學公司 用於製備４－（１－（４－（全氟乙氧基）苯基）－１ｈ－１，２，４－三唑－３－基）苯甲醯疊氮化物之改良方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460929A1 (de) * 1974-12-21 1976-06-24 Boehringer Sohn Ingelheim Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
DE3138397A1 (de) * 1981-09-26 1983-04-07 Hoechst Ag, 6230 Frankfurt "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen"
US4980379A (en) * 1988-06-30 1990-12-25 The University Of Virginia Use of adenosine antagonists in the treatment of bradyarrhythmias and hemodynamic depression associated with cardiopulmonary resucitation and/or cardiovascular collapse
DE3843117A1 (de) * 1988-12-22 1990-06-28 Boehringer Ingelheim Kg Neue xanthinderivate mit adenosin-antagonistischer wirkung
JPH06102662B2 (ja) * 1989-09-01 1994-12-14 協和醗酵工業株式会社 キサンチン誘導体
DE4019892A1 (de) * 1990-06-22 1992-01-02 Boehringer Ingelheim Kg Neue xanthinderivate
DE4205306B4 (de) * 1992-02-21 2005-11-24 Glüsenkamp, Karl-Heinz, Dr. Säureamide, Arzneimittel mit denselben und Verfahren zur Herstellung von Säureamiden
US5288721A (en) * 1992-09-22 1994-02-22 Cell Therapeutics, Inc. Substituted epoxyalkyl xanthines
WO1994016702A1 (en) * 1993-01-26 1994-08-04 Kyowa Hakko Kogyo Co., Ltd. Remedy for irregular bowel movement
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists

Also Published As

Publication number Publication date
AU728439B2 (en) 2001-01-11
DE69626705T2 (de) 2003-09-18
US5736528A (en) 1998-04-07
CA2238736C (en) 2003-09-16
JP2000502712A (ja) 2000-03-07
KR19990076916A (ko) 1999-10-25
ES2190487T3 (es) 2003-08-01
NZ326608A (en) 2000-04-28
BR9612324A (pt) 1999-12-28
CN1206420A (zh) 1999-01-27
CN1163502C (zh) 2004-08-25
EP1019426B1 (en) 2003-03-12
AU1522097A (en) 1997-07-28
DE69626705D1 (de) 2003-04-17
DK1019426T3 (da) 2003-07-14
US5998387A (en) 1999-12-07
CA2238736A1 (en) 1997-07-10
WO1997024363A1 (en) 1997-07-10
EP1019426A1 (en) 2000-07-19
ATE234322T1 (de) 2003-03-15

Similar Documents

Publication Publication Date Title
ATE187726T1 (de) A1 adenosin rezeptor agonisten und antagonisten
PT1019426E (pt) Agonistas e antagonistas do receptor de adenosina a1
TR200103607T2 (tr) Pürin Türevleri
ATE206432T1 (de) A3 -adenosin -rezeptor agonisten
TR200301971T4 (tr) Kısmi veya tam A1 agonistler N6 hetorosiklik 5'-Tiyo ikameli adenosin türevleri
DK0760811T3 (da) Imidazolderivater som histaminreceptor H3-modulatorer
DE69719816D1 (de) N6-heterocyclisch substituierte Adenosin-Derivate
ES2175079T3 (es) Derivados de indol utiles como inhibidores de cgmp-pde.
TR200200985T2 (tr) Pürin türevleri
WO1999064401A3 (en) Imidazolyl derivatives and their use as somatostatin receptor ligands
EP1027011A4 (en) ADMINISTRATION OF 5-HT RECEPTOR AGONISTS AND ANTAGONISTS INCLUDING ACTIVE SUBSTANCES FOR THE TREATMENT OF EARLY SEED EATING
DE69532162D1 (de) Cannabinoid-rezeptor-antagonisten
DE69133135D1 (de) Menschliche neuronale nikotin-acetylcholin-rezeptor-verbindungen und methoden ihres einsatzes
ES2196063T3 (es) Utilizacion de agentes antagonistas competitivos de progesterona para la preparacion de medicamentos destinados al tratamiento de hemorragias uterinas disfuncionales.
NO994850L (no) Farmakologiske midler
TR200301062T2 (tr) Adenosin reseptörü antagonistleri ve bu antagonistlerin yapım ve kullanım yöntemleri
PT1208100E (pt) Antagonistas selectivos de receptores de adenosina a2b
IL79264A0 (en) Tryptamine derivatives,pharmaceutical compositions containing them and their use in an assay for melatonin receptors
ES2120025T3 (es) Derivados de xantina utilizados como antagonistas de receptores de adenosina a1.
TR199800478T1 (xx) Diarilalkenilamin t�revleri
ATE342734T1 (de) Adenosin a1 antagonisten gegen männliche sterilität
ATE277639T1 (de) Zusammensetzungen von adenosin a1 agonisten und 5ht3 agonisten
AR247200A1 (es) Procedimiento para preparar una nueva clase de agentes medicinales piperidinilicos, utiles como agentes antitromboticos y como antagonistas de los receptores de 5ht2 de serotonina.
IT1281503B1 (it) Combinazioni di pirrolobenzotiazepine con analoghi di nucleosidi per la terapia dell'aids.
IT1295356B1 (it) Derivati chinolinici, procedimento per la loro preparazione e uso come antagonisti del recettore nk3